Trang kết quả 13 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (738)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (12)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- Nasdaq (1)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2611)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2611)
Công nghệ sinh học (2611)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Bavarian Nordic A/S BV3.F | $19.82 21.67 USD |
-0.5
|
$1.57B 1.71B USD | $340 371.67 USD | $19.5 21.31 USD | $20.2 22.08 USD | $1.57B 1.71B USD | 11.72 | $1.69 1.85 USD | |
| PeptiDream PPTDF | $12 — |
0
|
$1.7B — | $80 — | $11.21 — | $11.21 — | $1.7B — | 14.81 | $0.81 — | |
| Genus GENSF | $25.1 — |
0
|
$1.65B — | $300 — | $25.1 — | $25.1 — | $1.65B — | 0 | -$0.08 — | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $25K 28.44K USD | $25.25 28.73 USD | $26.25 29.87 USD | $1.45B 1.65B USD | 11.06 | $2.29 2.61 USD | |
| BioArctic AB (publ) 0RV2.IL | $167.85 16.38 USD |
-2.92
|
$16.79B 1.64B USD | $89.66K 8.75K USD | $161.3 15.74 USD | $184.9 18.05 USD | $16.79B 1.64B USD | 54.67 | $3.07 0.3 USD | |
| Galapagos GLPGF | $22.39 — |
0
|
$1.59B — | $190 — | $26.2 — | $26.2 — | $1.59B — | 0 | -$0.02 — | |
| Ascentage Pharma Group International 36X.F | $4.12 4.5 USD |
-6.36
|
$1.45B 1.58B USD | $7K 7.65K USD | $4.12 4.5 USD | $4.14 4.53 USD | $1.45B 1.58B USD | 0 | -$0.16 -0.1 USD | |
| Biotest Aktiengesellschaft BIO3.F | $29.8 32.58 USD |
+0.68
|
$1.44B 1.58B USD | $150 163.97 USD | $29.8 32.58 USD | $29.8 32.58 USD | $1.44B 1.58B USD | 45.15 | $0.66 0.72 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.4 46.35 USD |
0
|
$1.43B 1.57B USD | $20 21.86 USD | $42.4 46.35 USD | $42.4 46.35 USD | $1.43B 1.57B USD | 64.24 | $0.66 0.72 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $30 32.79 USD |
0
|
$1.43B 1.57B USD | $0 0 USD | $30 32.79 USD | $30 32.79 USD | $1.43B 1.57B USD | 45.45 | $0.66 0.72 USD | |
| Biotest Aktiengesellschaft BIO.F | $42 45.91 USD |
0
|
$1.43B 1.57B USD | $70 76.52 USD | $42 45.91 USD | $42 45.91 USD | $1.43B 1.57B USD | 63.63 | $0.66 0.72 USD | |
| Galapagos NV GXE.F | $21.34 23.33 USD |
+1.72
|
$1.42B 1.55B USD | $30 32.79 USD | $20.62 22.54 USD | $21.34 23.33 USD | $1.42B 1.55B USD | 0 | -$0.02 -0.02 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $24 26.24 USD |
0
|
$1.41B 1.54B USD | $15 16.4 USD | $24 26.24 USD | $24 26.24 USD | $1.41B 1.54B USD | 2.33 | $10.26 11.22 USD | |
| Galapagos NV GLPG.VI | $21.22 23.2 USD |
+0.28
|
$1.4B 1.53B USD | $0 0 USD | $21.1 23.07 USD | $21.22 23.2 USD | $1.4B 1.53B USD | 0 | -$0.02 -0.02 USD | |
| Pharma Mar PHMMF | $88.18 — |
0
|
$1.52B — | $100 — | $105.6 — | $105.6 — | $1.52B — | 52.17 | $1.69 — | |
| Centessa Pharmaceuticals plc 260.F | $10 10.93 USD |
-0.99
|
$1.39B 1.52B USD | $0 0 USD | $10 10.93 USD | $10.3 11.26 USD | $1.39B 1.52B USD | 0 | -$1.82 -1.9 USD | |
| Galapagos NV GXEA.F | $20.8 22.74 USD |
-1.89
|
$1.38B 1.51B USD | $20 21.86 USD | $20.8 22.74 USD | $20.8 22.74 USD | $1.38B 1.51B USD | 0 | -$0.02 -0.02 USD | |
| Pharma Mar, S.A. 0RC6.IL | $75.78 82.83 USD |
+0.53
|
$1.37B 1.5B USD | $353 385.88 USD | $75.1 82.09 USD | $75.9 82.97 USD | $1.37B 1.5B USD | 68.26 | $1.11 1.21 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $6.41 7.01 USD |
-0.65
|
$1.35B 1.48B USD | $130 142.11 USD | $6.41 7.01 USD | $6.41 7.01 USD | $1.35B 1.48B USD | 0 | -$0.38 -0.4 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $2.68 2.93 USD |
-4.96
|
$1.33B 1.45B USD | $196 214.25 USD | $2.68 2.93 USD | $2.68 2.93 USD | $1.33B 1.45B USD | 12.18 | $0.22 0.24 USD | |
| Pharma Mar, S.A. PMRA.F | $75 81.99 USD |
-0.33
|
$1.32B 1.44B USD | $16 17.49 USD | $75 81.99 USD | $75 81.99 USD | $1.32B 1.44B USD | 50.33 | $1.49 1.63 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $14.7 16.07 USD |
-1.34
|
$1.29B 1.41B USD | $300 327.94 USD | $14.7 16.07 USD | $14.7 16.07 USD | $1.29B 1.41B USD | 0 | -$2.96 -3.2 USD | |
| Genus plc GBE.F | $19.6 21.43 USD |
+3.16
|
$1.29B 1.41B USD | $19 20.77 USD | $19.6 21.43 USD | $19.6 21.43 USD | $1.29B 1.41B USD | 0 | -$0.07 -0.07 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.34 1.47 USD |
-6.28
|
$1.29B 1.41B USD | $2K 2.19K USD | $1.34 1.47 USD | $1.4 1.53 USD | $1.29B 1.41B USD | 0 | -$0.19 -0.2 USD | |
| Vir Biotechnology, Inc. VIR.MX | $172 10.18 USD |
0
|
$23.59B 1.4B USD | $0 0 USD | $172 10.18 USD | $172 10.18 USD | $23.59B 1.4B USD | 0 | -$78.1 -4.6 USD | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $13.9 15.19 USD |
-5.44
|
$1.24B 1.35B USD | $0 0 USD | $13.9 15.19 USD | $14.3 15.63 USD | $1.24B 1.35B USD | 0 | -$2.96 -3.2 USD | |
| POINT Biopharma Global PNT | $12.5 — |
0
|
$1.33B — | $0 — | $0 — | $0 — | $1.33B — | 0 | $0 — | |
| MannKind Corporation NNFN.F | $3.93 4.3 USD |
-2.46
|
$1.21B 1.33B USD | $100 109.31 USD | $3.93 4.3 USD | $3.93 4.3 USD | $1.21B 1.33B USD | 43.66 | $0.09 0.1 USD | |
| Immunocore Holdings plc 6YG.F | $24.2 26.45 USD |
+1.68
|
$1.21B 1.32B USD | $0 0 USD | $23.2 25.36 USD | $24.2 26.45 USD | $1.21B 1.32B USD | 0 | -$0.9 -0.9 USD | |
| Jubilant Ingrevia Limited JUBLINGREA.BO | $668.95 8.09 USD |
+0.38
|
$105.76B 1.28B USD | $3.43K 41.5 USD | $661.85 8.01 USD | $682.15 8.25 USD | $105.76B 1.28B USD | 51.22 | $13.06 0.16 USD | |
| Immunocore Holdings plc 6YG.MU | $23.4 25.58 USD |
-1.68
|
$1.17B 1.28B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.17B 1.28B USD | 0 | -$1.32 -1.4 USD | |
| Jubilant Ingrevia Limited JUBLINGREA.NS | $668.25 8.08 USD |
+0.24
|
$105.65B 1.28B USD | $241.11K 2.92K USD | $661.65 8 USD | $682.75 8.26 USD | $105.65B 1.28B USD | 51.12 | $13.07 0.16 USD | |
| Mesoblast Limited LWB.F | $0.88 0.96 USD |
-4.86
|
$1.14B 1.25B USD | $1.9K 2.08K USD | $0.88 0.96 USD | $0.88 0.96 USD | $1.14B 1.25B USD | 0 | -$0.08 -0.08 USD | |
| Novavax, Inc. NVAX.MX | $123 7.28 USD |
0
|
$20.66B 1.22B USD | $3.04K 179.95 USD | $123 7.28 USD | $123 7.28 USD | $20.66B 1.22B USD | 0 | -$24.71 -1.4 USD | |
| CTI BioPharma CTIC | $9.07 — |
0
|
$1.2B — | $0 — | $0 — | $0 — | $1.2B — | 0 | $0 — | |
| Celldex Therapeutics, Inc. TCE2.F | $15.7 17.16 USD |
+1.29
|
$1.09B 1.19B USD | $20 21.86 USD | $15.7 17.16 USD | $15.7 17.16 USD | $1.09B 1.19B USD | 0 | -$2.16 -2.3 USD | |
| EQRx EQRX | $2.34 — |
0
|
$1.14B — | $0 — | $0 — | $0 — | $1.14B — | 0 | $0 — | |
| Adaptive Biotechnologies Corporation 1HM.MU | $6.85 7.49 USD |
-1.89
|
$1.02B 1.11B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.02B 1.11B USD | 0 | -$0.95 -1.03 USD | |
| Liquidia Corporation LT4.MU | $11.91 13.02 USD |
-1.24
|
$1.02B 1.11B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.02B 1.11B USD | 0 | -$1.46 -1.5 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $6.32 6.9 USD |
-6.93
|
$1B 1.1B USD | $1K 1.09K USD | $6.32 6.9 USD | $6.44 7.04 USD | $1B 1.1B USD | 0 | -$1.08 -1.1 USD | |
| Liquidia Corporation LT4.F | $11.77 12.87 USD |
-2.4
|
$1B 1.1B USD | $171 186.93 USD | $11.77 12.87 USD | $11.77 12.87 USD | $1B 1.1B USD | 0 | -$1.46 -1.5 USD | |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD | |
| Calliditas Therapeutics AB (publ) CALT | $40 — |
0
|
$1.1B — | $0 — | $0 — | $0 — | $1.1B — | 0 | $0 — | |
| Adaptive Biotechnologies Corporation 1HM.F | $6.65 7.27 USD |
-1.8
|
$995.98M 1.09B USD | $582 636.2 USD | $6.65 7.27 USD | $6.65 7.27 USD | $995.98M 1.09B USD | 0 | -$0.95 -1.03 USD | |
| Liquidia Corporation LT4.SG | $11.74 12.83 USD |
-1.43
|
$993.63M 1.09B USD | $0 0 USD | $11.73 12.82 USD | $11.74 12.83 USD | $993.63M 1.09B USD | 0 | -$1.48 -1.6 USD | |
| Innoviva, Inc. HVE.F | $15.8 17.27 USD |
-1.25
|
$991.78M 1.08B USD | $211 230.65 USD | $15.6 17.05 USD | $15.8 17.27 USD | $991.78M 1.08B USD | 49.37 | $0.32 0.35 USD | |
| SanBio Company SNBIF | $6.55 — |
0
|
$1.08B — | $1K — | $3.85 — | $3.85 — | $1.08B — | 0 | -$0.28 — | |
| Raspberry Pi Holdings PLC R 0IK.F | $5.02 5.49 USD |
-1.95
|
$979.7M 1.07B USD | $100 109.31 USD | $5.02 5.49 USD | $5.12 5.6 USD | $979.7M 1.07B USD | 100.40 | $0.05 0.05 USD | |
| Ardelyx, Inc. 41X.F | $3.97 4.34 USD |
-0.08
|
$974.66M 1.07B USD | $485 530.17 USD | $3.97 4.34 USD | $3.97 4.34 USD | $974.66M 1.07B USD | 0 | -$0.15 -0.1 USD | |
| Calliditas Therapeutics AB (publ) LC8A.F | $35 38.26 USD |
0
|
$973.33M 1.06B USD | $0 0 USD | $0 0 USD | $0 0 USD | $973.33M 1.06B USD | 0 | $0 0 USD | |
| Calliditas Therapeutics AB (publ) LC8.F | $17.83 19.49 USD |
0
|
$963.42M 1.05B USD | $0 0 USD | $0 0 USD | $0 0 USD | $963.42M 1.05B USD | 0 | $0 0 USD | |
| Cerus Corporation CU2.DE | $5.14 5.62 USD |
0
|
$942.01M 1.03B USD | $0 0 USD | $0 0 USD | $0 0 USD | $942.01M 1.03B USD | 0 | $0 0 USD | |
| Viridian Therapeutics, Inc. 1S1.F | $11.28 12.33 USD |
-7.47
|
$919.15M 1B USD | $400 437.25 USD | $10.97 11.99 USD | $11.28 12.33 USD | $919.15M 1B USD | 0 | -$2.71 -2.9 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $2.79 3.05 USD |
-5.35
|
$916.25M 1B USD | $500 546.57 USD | $2.79 3.05 USD | $2.79 3.05 USD | $916.25M 1B USD | 0 | -$1.13 -1.2 USD | |
| Aurinia Pharmaceuticals Inc. IKAP.F | $6.59 7.2 USD |
-2.4
|
$916.18M 1B USD | $185 202.23 USD | $6.59 7.2 USD | $6.59 7.21 USD | $916.18M 1B USD | 164.75 | $0.04 0.04 USD | |
| Gracell Biotechnologies GRCL | $10.25 — |
0
|
$989.87M — | $0 — | $0 — | $0 — | $989.87M — | 0 | $0 — | |
| CK Life Sciences Int'l., (Holdings) Inc. LSI.F | $0.08 0.09 USD |
+3.82
|
$896.34M 979.82M USD | $0 0 USD | $0.08 0.09 USD | $0.08 0.09 USD | $896.34M 979.82M USD | 0 | $0 0 USD | |
| Poseida Therapeutics, Inc. 2RZ.F | $9.05 9.89 USD |
0
|
$895.18M 978.56M USD | $0 0 USD | $0 0 USD | $0 0 USD | $895.18M 978.56M USD | 0 | $0 0 USD | |
| Neuren Pharmaceuticals NURPF | $7.63 — |
0
|
$976.59M — | $720 — | $6.9 — | $6.9 — | $976.59M — | 11.22 | $0.68 — | |
| Sangamo Therapeutics, Inc. GBY.DE | $5.05 5.52 USD |
0
|
$884.7M 967.1M USD | $0 0 USD | $0 0 USD | $0 0 USD | $884.7M 967.1M USD | 0 | $0 0 USD | |
| Novavax, Inc. NVV1.F | $5.42 5.92 USD |
-3.06
|
$878.7M 960.54M USD | $268 292.96 USD | $5.41 5.91 USD | $5.55 6.06 USD | $878.7M 960.54M USD | 0 | -$1.08 -1.1 USD | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $9.65 10.55 USD |
-0.52
|
$855.34M 935.01M USD | $8 8.75 USD | $9.65 10.55 USD | $9.65 10.55 USD | $855.34M 935.01M USD | 0 | -$3.28 -3.5 USD | |
| Poseida Therapeutics PSTX | $9.5 — |
0
|
$925.93M — | $0 — | $0 — | $0 — | $925.93M — | 0 | $0 — | |
| Ergomed plc ERGO.L | $1,346 1721.45 USD |
0
|
$701.05M 896.6M USD | $0 0 USD | $0 0 USD | $0 0 USD | $701.05M 896.6M USD | 0 | $0 0 USD | |
| Wave Life Sciences Ltd. 1U5.F | $5.2 5.68 USD |
-5.45
|
$803.72M 878.57M USD | $150 163.97 USD | $5.2 5.68 USD | $5.2 5.68 USD | $803.72M 878.57M USD | 0 | -$0.62 -0.6 USD | |
| Ergomed plc 2EM.F | $14.68 16.05 USD |
0
|
$788.59M 862.04M USD | $0 0 USD | $0 0 USD | $0 0 USD | $788.59M 862.04M USD | 0 | $0 0 USD | |
| Intercept Pharmaceuticals, Inc. I4P.F | $17.52 19.15 USD |
0
|
$738.99M 807.82M USD | $0 0 USD | $0 0 USD | $0 0 USD | $738.99M 807.82M USD | 0 | $0 0 USD | |
| Avid Bioservices CDMO | $12.49 — |
0
|
$798.9M — | $0 — | $0 — | $0 — | $798.9M — | 0 | $0 — | |
| Intercept Pharmaceuticals ICPT | $19 — |
0
|
$794.69M — | $0 — | $0 — | $0 — | $794.69M — | 0 | $0 — | |
| Ascletis Pharma ASCLF | $0.6199 — |
0
|
$774.9M — | $200 — | $0.93 — | $0.93 — | $774.9M — | 0 | -$0.04 — | |
| Icosavax ICVX | $15.31 — |
0
|
$769.04M — | $0 — | $0 — | $0 — | $769.04M — | 0 | $0 — | |
| Chimerix, Inc. CXF.F | $7.46 8.15 USD |
-0.93
|
$700.75M 766.02M USD | $130 142.11 USD | $7.35 8.03 USD | $7.48 8.18 USD | $700.75M 766.02M USD | 0 | -$0.87 -0.9 USD | |
| Anavex Life Sciences Corp. 12X1.F | $7.85 8.58 USD |
-0.83
|
$678.48M 741.67M USD | $185 202.23 USD | $7.85 8.58 USD | $7.85 8.58 USD | $678.48M 741.67M USD | 0 | -$0.49 -0.5 USD | |
| Pharvaris N.V. 9EN.F | $11.8 12.9 USD |
0
|
$669.94M 732.34M USD | $200 218.63 USD | $11.8 12.9 USD | $12 13.12 USD | $669.94M 732.34M USD | 0 | -$2.48 -2.7 USD | |
| Supriya Lifescience Limited SUPRIYA.BO | $744.5 9.01 USD |
+1.58
|
$59.92B 724.93M USD | $39.06K 472.61 USD | $733.65 8.88 USD | $760.3 9.2 USD | $59.92B 724.93M USD | 34.30 | $21.7 0.26 USD | |
| Supriya Lifescience Limited SUPRIYA.NS | $743.9 9 USD |
+1.49
|
$59.87B 724.34M USD | $335.83K 4.06K USD | $733.5 8.87 USD | $761.05 9.21 USD | $59.87B 724.34M USD | 34.28 | $21.7 0.26 USD | |
| HBM Holdings Limited 6XY.F | $0.7399 0.81 USD |
-9.2
|
$661.04M 722.61M USD | $24K 26.24K USD | $0.7399 0.81 USD | $0.7399 0.81 USD | $661.04M 722.61M USD | 0 | $0 0 USD | |
| Sunmax Biotechnology Co., Ltd. 4728.TWO | $417 13.25 USD |
+4.77
|
$22.71B 721.65M USD | $104.48K 3.32K USD | $398 12.65 USD | $418.5 13.3 USD | $22.71B 721.65M USD | 33.44 | $12.47 0.4 USD | |
| Geron Corporation GON.F | $1.02 1.11 USD |
-11.19
|
$649.33M 709.81M USD | $3K 3.28K USD | $1.02 1.11 USD | $1.08 1.18 USD | $649.33M 709.81M USD | 0 | -$0.24 -0.2 USD | |
| CStone Pharmaceuticals CSPHF | $0.52 — |
0
|
$702.16M — | $800 — | $0.1199 — | $0.1199 — | $702.16M — | 0 | -$0.01 — | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $5.28 5.77 USD |
+4.59
|
$642.29M 702.11M USD | $120 131.18 USD | $5.28 5.77 USD | $5.28 5.77 USD | $642.29M 702.11M USD | 0 | -$2.41 -2.6 USD | |
| AbCellera Biologics Inc. 8QQ.F | $2.13 2.33 USD |
+0.28
|
$640.42M 700.07M USD | $1.1K 1.2K USD | $2.1 2.3 USD | $2.13 2.33 USD | $640.42M 700.07M USD | 0 | -$0.49 -0.5 USD | |
| CureVac N.V. CVAC.VI | $2.82 3.08 USD |
-2.56
|
$634.04M 693.09M USD | $0 0 USD | $2.81 3.08 USD | $2.82 3.09 USD | $634.04M 693.09M USD | 3.91 | $0.72 0.79 USD | |
| Intellia Therapeutics, Inc. 38I.F | $6.02 6.58 USD |
-6.2
|
$630.25M 688.95M USD | $590 644.95 USD | $6.02 6.58 USD | $6.02 6.58 USD | $630.25M 688.95M USD | 0 | -$4.63 -5.06 USD | |
| Xeris Biopharma Holdings, Inc. 2B30.F | $3.73 4.08 USD |
+3.9
|
$617.84M 675.38M USD | $300 327.94 USD | $3.73 4.08 USD | $3.73 4.08 USD | $617.84M 675.38M USD | 0 | -$0.33 -0.3 USD | |
| Prestige BioPharma Limited 950210.KS | $14,460 10.91 USD |
+0.56
|
$868.99B 655.95M USD | $0 0 USD | $0 0 USD | $0 0 USD | $868.99B 655.95M USD | 0 | $0 0 USD | |
| Takara Bio Inc. 4974.T | $779 5.26 USD |
-0.26
|
$93.8B 633.2M USD | $116.2K 784.38 USD | $775 5.23 USD | $786 5.31 USD | $93.8B 633.2M USD | 0 | -$0.47 -0.003 USD | |
| Takara Bio Inc. TF2.F | $4.5 4.92 USD |
-0.44
|
$576.39M 630.07M USD | $250 273.28 USD | $4.5 4.92 USD | $4.58 5.01 USD | $576.39M 630.07M USD | 0 | $0 0 USD | |
| Xencor, Inc. XE9.F | $7.8 8.53 USD |
-3.7
|
$570.88M 624.05M USD | $415 453.65 USD | $7.8 8.53 USD | $7.8 8.53 USD | $570.88M 624.05M USD | 0 | -$3.16 -3.4 USD | |
| Ascletis Pharma Inc. 2VJ.F | $0.5799 0.63 USD |
-17.14
|
$566.25M 618.99M USD | $1.5K 1.64K USD | $0.5799 0.63 USD | $0.5899 0.64 USD | $566.25M 618.99M USD | 0 | -$0.04 -0.04 USD | |
| Pharming PHGUF | $0.9 — |
0
|
$615.54M — | $1K — | $0.9 — | $0.9 — | $615.54M — | 0 | -$0.02 — | |
| Niagen Bioscience CDXC | $7.87 — |
0
|
$611.9M — | $0 — | $0 — | $0 — | $611.9M — | 0 | $0 — | |
| GNI Group Ltd. 3G6.F | $10.7 11.7 USD |
-1.83
|
$554.63M 606.28M USD | $100 109.31 USD | $10.7 11.7 USD | $10.7 11.7 USD | $554.63M 606.28M USD | 82.30 | $0.13 0.14 USD | |
| Valneva SE INRLF | $2.82 — |
0
|
$605.11M — | $1K — | $3.5 — | $3.5 — | $605.11M — | 0 | -$0.09 — | |
| Replimune Group, Inc. 7R8.F | $6.65 7.27 USD |
+2.31
|
$535.76M 585.66M USD | $50 54.66 USD | $6.65 7.27 USD | $6.8 7.43 USD | $535.76M 585.66M USD | 0 | -$2.71 -2.9 USD | |
| Altimmune, Inc. ALT1.MX | $127 7.52 USD |
0
|
$9.78B 579.14M USD | $0 0 USD | $127 7.52 USD | $127 7.52 USD | $9.78B 579.14M USD | 0 | -$26.94 -1.5 USD | |
| Valneva SE AYJ0.F | $5.9 6.45 USD |
-3.28
|
$516.04M 564.1M USD | $319 348.71 USD | $5.9 6.45 USD | $6.15 6.72 USD | $516.04M 564.1M USD | 0 | -$0.16 -0.1 USD | |
| Arbutus Biopharma Corporation I9DN.F | $2.69 2.94 USD |
-5.36
|
$514.32M 562.22M USD | $180 196.76 USD | $2.69 2.94 USD | $2.69 2.94 USD | $514.32M 562.22M USD | 0 | -$0.34 -0.3 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | $10.1 11.04 USD |
-2.88
|
$511.82M 559.49M USD | $56 61.22 USD | $10.1 11.04 USD | $10.1 11.04 USD | $511.82M 559.49M USD | 0 | -$3.32 -3.6 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||